Pre-exposure Prophylaxis: The Delivery Challenge

Por Venter, Willem D. F.
Publicado no Front Public Health (2018)

The ADVANCE study: a groundbreaking trial to evaluate a candidate universal antiretroviral regimen

Por Venter, Willem D.F., Clayden, Polly, Serenata, Celicia
Publicado no Curr Opin HIV AIDS (2017)

An overview of tenofovir and renal disease for the HIV-treating clinician

Por Venter, Willem D.F., Fabian, June, Feldman, Charles
Publicado no South Afr J HIV Med (2018)

Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa

Por Wallis, Carole L., Mellors, John W., Venter, Willem D. F., Sanne, Ian, Stevens, Wendy
Publicado em 2011

Evaluation of the Abbott m2000 RealTime Human Immunodeficiency Virus Type 1 (HIV-1) Assay for HIV Load Monitoring in South Africa Compared to the Roche Cobas AmpliPrep-Cobas Amplic...

Por Scott, Lesley E., Noble, Lara D., Moloi, Jackie, Erasmus, Linda, Venter, Willem D. F., Stevens, Wendy
Publicado em 2009

Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial

Por Venter, Willem D. F., Majam, Mohammed, Akpomiemie, Godspower, Arulappan, Natasha, Moorhouse, Michelle, Mashabane, Nonkululeko, Chersich, Matthew F.
Publicado no BMC Public Health (2017)